Get started
Author

Takeshi Yokoe

Observed names: T Yokoe, T. Yokoe, TAKESHI YOKOE, Takeshi YOKOE, Yokoe, Takeshi
Observed institutions: Kyushu University, Gunma University, Mie University, Japan Science and Technology Agency, Mie Prefectural General Medical Center, Medical Institute of Bioregulation, Kyushu University, Meiwa Hospital
ORCID: 0000-0002-9013-7718
Observed ORCID: 0000-0002-9013-7718
OpenAlex ID: A5075189543
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
2009 · Susumu Saigusa, Koji Tanaka, et al. · Annals of Surgical Oncology · 324
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
2019 · Yoshinaga Okugawa, Yuji Toiyama, et al. · Annals of Surgery · 283
Preoperative C‐reactive protein as a prognostic and therapeutic marker for colorectal cancer
2008 · Yuhki Koike, Chikao Miki, et al. · Journal of Surgical Oncology · 148
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
2009 · Takeshi Yokoe, Yuji Toiyama, et al. · Annals of Surgical Oncology · 127
Prognostic Significance of Host‐ and Tumor‐Related Factors in Patients with Gastric Cancer
2009 · Yasuhiko Mohri, Kouji Tanaka, et al. · World Journal of Surgery · 114
Tripartite Motif-Containing 29 (TRIM29) Is a Novel Marker for Lymph Node Metastasis in Gastric Cancer
2007 · Yoshimasa Kosaka, Hiroshi Inoue, et al. · Annals of Surgical Oncology · 104
Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia
2017 · Yumiko Shirai, Yoshinaga Okugawa, et al. · Scientific Reports · 86
PDF
Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy
2010 · Susumu Saigusa, Yuji Toiyama, et al. · Annals of Surgical Oncology · 53
Efficient Identification of a Novel Cancer/Testis Antigen for Immunotherapy Using Three-Step Microarray Analysis
2008 · Takeshi Yokoe, Fumiaki Tanaka, et al. · Cancer Research · 49
PDF
Clinical significance of growth differentiation factor 11 in colorectal cancer
2007 · Masaki Mori, Koshi Mimori, et al. · International Journal of Oncology · 49
PDF
Prognostic Potential of Lymphocyte–C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy
2020 · Yoshinaga Okugawa, Yuji Toiyama, et al. · Journal of Gastrointestinal Surgery · 46
DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness
2010 · Yuji Toiyama, Yasuhiro Inoue, et al. · Journal of Gastroenterology · 46
Gene Expression Profiles of Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1 with Special Reference to Local Responsiveness to Neoadjuvant Chemoradiotherapy and Disease Recurrence After Rectal Cancer Surgery
2010 · Y. Toiyama, Y. Inoue, et al. · Clinical Oncology · 44
Clinical Significance of CD133 and Hypoxia Inducible Factor-1α Gene Expression in Rectal Cancer after Preoperative Chemoradiotherapy
2010 · S. Saigusa, K. Tanaka, et al. · Clinical Oncology · 38
Geriatric nutritional risk index predicts cancer prognosis in patients with local advanced rectal cancer undergoing chemoradiotherapy followed by curative surgery
2021 · Shozo Ide, Yoshinaga Okugawa, et al. · World Journal of Surgical Oncology · 36
PDF
CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer
2011 · HIROMI YASUDA, KOJI TANAKA, et al. · Oncology Letters · 33
PDF
Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients
2020 · Akira Yamamoto, Yuji Toiyama, et al. · Surgery Today · 32
Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer
2021 · Yukina Kusunoki, Yoshinaga Okugawa, et al. · Clinical Nutrition · 31
Mitotic Checkpoint Genes, hsMAD2 and BubR1, in Oesophageal Squamous Cancer Cells and their Association with 5-fluorouracil and Cisplatin-based Radiochemotherapy
2008 · K. Tanaka, Y. Mohri, et al. · Clinical Oncology · 29
Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer
2018 · YOSHINAGA OKUGAWA, YUMIKO SHIRAI, et al. · Anticancer Research · 26
PDF
Soluble Intercellular Adhesion Molecule-1 as a Prognostic Marker for Stage II Colorectal Cancer Patients
2008 · Yuji Toiyama, Chikao Miki, et al. · Annals of Surgical Oncology · 26
Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer
2010 · Y Okugawa, C Miki, et al. · British Journal of Cancer · 24
PDF
Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer
2010 · Yasuhiro Inoue, Takehiko Yokobori, et al. · Annals of Surgical Oncology · 24
Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
2022 · Yoshinaga Okugawa, Takahito Kitajima, et al. · Journal of Clinical Medicine · 23
PDF
Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy
2011 · AYA KAWAMOTO, KOJI TANAKA, et al. · Experimental and Therapeutic Medicine · 21
PDF
Works count: 70
Citation count: 1,993
H-index: 23
I10-index: 34
Year
Topic
Type